{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T07:57:54Z","timestamp":1785484674007,"version":"3.56.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014421","name":"EA Pharma Co., Ltd","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014421","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>Inflammatory bowel disease (IBD), which includes Crohn\u2019s disease (CD) and ulcerative colitis (UC), requires long-term management. Besides pharmacotherapy, nutritional care is considered to be important; however, its real-world status in Japan remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, a web-based survey on 150 patients with IBD (CD, 75; UC, 75) was conducted between October 30 and November 4, 2025. Patient demographics, self-perceived relapse frequency, self-perceived relapse triggers, implementation of nutritional therapy, and the use of health management apps were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Patients with CD reported a higher self-perceived relapse frequency than did patients with UC (\u22651 episode\/year: 52% vs 32%) and were more likely to perceive diet as a self-perceived relapse trigger (77% vs 39%). Nutritional therapy was introduced in 53% of patients with CD and 12% of patients with UC, and 31% of patients with CD were currently using elemental diets. Most patients consumed 300-900\u2009kcal\/day, and some reported symptom improvement, although discontinuation was often due to the physician\u2019s decision or difficulty in intake. Dietary management awareness was higher in the CD group than in the UC group (77% vs 48%), whereas supplement use showed no significant difference (37% vs 29%). Health app usage was &amp;lt;10%, with common reasons for nonuse being a lack of awareness and perceived necessity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Nutritional therapy is more frequently administered to patients with CD in Japan, suggesting its clinical relevance. Strategies are required to enhance dietary guidance, support the continued use of elemental diets, and promote digital health tools.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/crocol\/otag081","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:48:15Z","timestamp":1784116095000},"source":"Crossref","is-referenced-by-count":0,"title":["Nutrition management and self-perceived relapse triggers in patients with inflammatory bowel disease: results from the 3R web-based survey"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1195-0074","authenticated-orcid":false,"given":"Motohiro","family":"Esaki","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Saga University , Saga,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9786-3854","authenticated-orcid":false,"given":"Takayuki","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, School of Medicine, Iwate Medical University , Iwate,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5493-5675","authenticated-orcid":false,"given":"Fumihito","family":"Hirai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine, Fukuoka University , Fukuoka,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2054-394X","authenticated-orcid":false,"given":"Takahiro","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Medical Department, EA Pharma , Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7275-8009","authenticated-orcid":false,"given":"Yoshiyuki","family":"Hosoi","sequence":"additional","affiliation":[{"name":"Medical Department, EA Pharma , Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6319-1305","authenticated-orcid":false,"given":"Akira","family":"Oota","sequence":"additional","affiliation":[{"name":"Pharmaceutical Development Department, Data Science Group, EA Pharma , Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3357-7412","authenticated-orcid":false,"given":"Masaaki","family":"Higashikawa","sequence":"additional","affiliation":[{"name":"Pharmaceutical Development Department, Data Science Group, EA Pharma , Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0601-1674","authenticated-orcid":false,"given":"Minami","family":"Umeyama","sequence":"additional","affiliation":[{"name":"Medical Department, EA Pharma , Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2410-1032","authenticated-orcid":false,"given":"Masato","family":"Ueno","sequence":"additional","affiliation":[{"name":"Medical Department, EA Pharma , Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"2026073103063015500_otag081-B1","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1053\/j.gastro.2011.01.055","article-title":"Epidemiology and natural history of inflammatory bowel diseases","volume":"140","author":"Cosnes","year":"2011","journal-title":"Gastroenterology"},{"key":"2026073103063015500_otag081-B2","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1053\/j.gastro.2023.11.303","article-title":"AGA clinical practice update on diet and nutritional therapies in patients with inflammatory bowel disease: expert review","volume":"166","author":"Hashash","year":"2024","journal-title":"Gastroenterology"},{"key":"2026073103063015500_otag081-B3","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1111\/jgh.16939","article-title":"Understanding role of nutrition in inflammatory bowel disease: a comprehensive review with incorporation of AGA update","volume":"40","author":"Dhaliwal","year":"2025","journal-title":"J Gastroenterol Hepatol"},{"key":"2026073103063015500_otag081-B4","doi-asserted-by":"publisher","first-page":"668","DOI":"10.3390\/nu15030668","article-title":"Current nutritional therapies in inflammatory bowel disease: improving clinical remission rates and sustainability of Long-Term dietary therapies","volume":"15","author":"Reznikov","year":"2023","journal-title":"Nutrients"},{"key":"2026073103063015500_otag081-B5","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S2468-1253(23)00011-0","article-title":"Inflammation and malnutrition in inflammatory bowel disease","volume":"8","author":"Massironi","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026073103063015500_otag081-B6","doi-asserted-by":"publisher","first-page":"jjae177","DOI":"10.1093\/ecco-jcc\/jjae177","article-title":"Partial enteral nutrition in the management of crohn\u2019s disease: a systematic review and meta-analysis","volume":"19","author":"Jatkowska","year":"2025","journal-title":"J Crohns Colitis"},{"key":"2026073103063015500_otag081-B7","doi-asserted-by":"publisher","first-page":"3344","DOI":"10.1007\/s10620-024-08543-1","article-title":"Elemental diet as a therapeutic modality: a comprehensive review","volume":"69","author":"Nasser","year":"2024","journal-title":"Dig Dis Sci"},{"key":"2026073103063015500_otag081-B8","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/01.mib.0000161307.58327.96","article-title":"Impact of elemental diet on mucosal inflammation in patients with active Crohn\u2019s disease","volume":"11","author":"Yamamoto","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"2026073103063015500_otag081-B9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4103\/1319-3767.199110","article-title":"Therapeutic efficacy of an elemental diet for patients with crohn\u2019s disease","volume":"23","author":"Nakano","year":"2017","journal-title":"Saudi J Gastroenterol"},{"key":"2026073103063015500_otag081-B10","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1111\/j.1365-2036.2006.03120.x","article-title":"Effectiveness of an \u2018half elemental diet\u2019 as maintenance therapy for Crohn\u2019s disease","volume":"24","author":"Takagi","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"2026073103063015500_otag081-B11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41575-022-00738-z","article-title":"Improving IBD outcomes in the era of many treatment options","volume":"20","author":"Kobayashi","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026073103063015500_otag081-B12","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/ecco-jcc\/jjv052","article-title":"Internet-orientated assessment of QOL and actual treatment status in Japanese patients with inflammatory bowel disease","volume":"9","author":"Matsumoto","year":"2015","journal-title":"J Crohns Colitis"},{"key":"2026073103063015500_otag081-B13","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","article-title":"Clinical epidemiology of inflammatory bowel disease","volume":"126","author":"Loftus","year":"2004","journal-title":"Gastroenterology"},{"key":"2026073103063015500_otag081-B14","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.cgh.2007.09.002","article-title":"Clinical course in Crohn\u2019s disease","volume":"5","author":"Solberg","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026073103063015500_otag081-B15","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1080\/00365520802600961","article-title":"Clinical course during the first 10 years of ulcerative colitis","volume":"44","author":"Solberg","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"2026073103063015500_otag081-B16","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1093\/ecco-jcc\/jjab008","article-title":"Dietary intake pattern is associated with occurrence of flares","volume":"15","author":"Peters","year":"2021","journal-title":"J Crohns Colitis"},{"key":"2026073103063015500_otag081-B17","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.cgh.2020.01.046","article-title":"Dietary guidance from the International Organization for the Study of Inflammatory Bowel Diseases","volume":"18","author":"Levine","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026073103063015500_otag081-B18","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.sleep.2020.08.032","article-title":"Sleep quality and disease activity","volume":"75","author":"Hao","year":"2020","journal-title":"Sleep Med"},{"key":"2026073103063015500_otag081-B19","doi-asserted-by":"publisher","first-page":"jjae116","DOI":"10.1093\/ecco-jcc\/jjae116","article-title":"Chronic poor sleep and disease activity in UC","volume":"19","author":"Oyama","year":"2025","journal-title":"J Crohns Colitis"},{"key":"2026073103063015500_otag081-B20","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.cgh.2013.01.021","article-title":"Sleep disturbance and risk of active disease","volume":"11","author":"Ananthakrishnan","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026073103063015500_otag081-B21","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1111\/j.1572-0241.2000.02012.x","article-title":"Stress and exacerbation in ulcerative colitis","volume":"95","author":"Levenstein","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"2026073103063015500_otag081-B22","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1111\/j.1572-0241.2003.07717.x","article-title":"Psychosocial determinants of relapse","volume":"98","author":"Bitton","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"2026073103063015500_otag081-B23","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/apt.17202","article-title":"Psychological stress in IBD","volume":"56","author":"Black","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"2026073103063015500_otag081-B24","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00535-021-01784-1","article-title":"Evidence-based clinical practice guidelines for IBD 2020","volume":"56","author":"Nakase","year":"2021","journal-title":"J Gastroenterol"},{"key":"2026073103063015500_otag081-B25","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1002\/ibd.20238","article-title":"Long-term enteral nutrition and clinical\/endoscopic disease activities","volume":"13","author":"Yamamoto","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"2026073103063015500_otag081-B26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1365-2036.2006.03158.x","article-title":"Long-term enteral nutrition after resection","volume":"25","author":"Yamamoto","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"2026073103063015500_otag081-B27","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/codi.14922","article-title":"Preoperative enteral nutrition and postop complications","volume":"22","author":"Yamamoto","year":"2020","journal-title":"Colorectal Dis"},{"key":"2026073103063015500_otag081-B28","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41575-024-01035-7","article-title":"Therapeutic toolkit for IBD","volume":"22","author":"Vieujean","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026073103063015500_otag081-B29","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1056\/NEJMra1907607","article-title":"C. New biologics and small molecules for IBD","volume":"385","author":"Baumgart","year":"2021","journal-title":"N Engl J Med"},{"key":"2026073103063015500_otag081-B30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00535-019-01634-1","article-title":"EN with anti-TNF maintenance","volume":"55","author":"Hirai","year":"2020","journal-title":"J Gastroenterol"},{"key":"2026073103063015500_otag081-B31","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s10620-012-2374-2","article-title":"EN + infliximab in adults","volume":"58","author":"Hirai","year":"2013","journal-title":"Dig Dis Sci"},{"key":"2026073103063015500_otag081-B32","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/jgh.13969","article-title":"EN to reduce adalimumab loss of response","volume":"33","author":"Sugita","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"2026073103063015500_otag081-B33","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1007\/s10620-014-3493-8","article-title":"EN with infliximab schedule therapy","volume":"60","author":"Kamata","year":"2015","journal-title":"Dig Dis Sci"},{"key":"2026073103063015500_otag081-B34","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1080\/00365520510023639","article-title":"Infliximab under nutritional therapy","volume":"40","author":"Matsumoto","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"2026073103063015500_otag081-B35","doi-asserted-by":"publisher","first-page":"e31131","DOI":"10.1371\/journal.pone.0031131","article-title":"Plasma amino acid biomarkers","volume":"7","author":"Hisamatsu","year":"2012","journal-title":"PLoS One"},{"key":"2026073103063015500_otag081-B36","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1053\/j.gastro.2008.09.062","article-title":"Histidine ameliorates colitis","volume":"136","author":"Andou","year":"2009","journal-title":"Gastroenterology"},{"key":"2026073103063015500_otag081-B37","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.3390\/ijms25063448","article-title":"ED tryptophan and AHR","volume":"25","author":"Kubota","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2026073103063015500_otag081-B38","doi-asserted-by":"publisher","first-page":"7086939","DOI":"10.1155\/2020\/7086939","article-title":"Half-ED shifts gut microbiota","volume":"2020","author":"Miyoshi","year":"2020","journal-title":"Gastroenterol Res Pract"},{"key":"2026073103063015500_otag081-B39","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1093\/ibd\/izae124","article-title":"Exclusive EN reduces immunostimulatory fecal products","volume":"30","author":"Kerbiriou","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"2026073103063015500_otag081-B40","doi-asserted-by":"publisher","first-page":"otad069","DOI":"10.1093\/crocol\/otad069","article-title":"Japan IBD patient survey","volume":"5","author":"Matsumoto","year":"2023","journal-title":"Crohns Colitis 360"},{"key":"2026073103063015500_otag081-B41","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.3390\/nu17111879","article-title":"Dietary interventions and supplementation in IBD","volume":"17","author":"Barberio","year":"2025","journal-title":"Nutrients"},{"key":"2026073103063015500_otag081-B42","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1093\/ecco-jcc\/jjad075","article-title":"E-health for IBD","volume":"17","author":"Kuriakose Kuzhiyanjal","year":"2023","journal-title":"J Crohns Colitis"},{"key":"2026073103063015500_otag081-B43","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1053\/j.gastro.2024.12.024","article-title":"Wearables identify IBD flares","volume":"168","author":"Hirten","year":"2025","journal-title":"Gastroenterology"},{"key":"2026073103063015500_otag081-B44","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cgh.2025.06.003","article-title":"Wearables and sleep trajectories in IBD","volume":"24","author":"Hirten","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026073103063015500_otag081-B45","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/s00535-025-02295-z","article-title":"Nationwide IBD prevalence Japan 2023","volume":"60","author":"Tsutsui","year":"2025","journal-title":"J Gastroenterol"},{"key":"2026073103063015500_otag081-B46","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1053\/j.gastro.2013.04.007","article-title":"Asia-Pacific IBD epidemiology","volume":"145","author":"Ng","year":"2013","journal-title":"Gastroenterology"},{"key":"2026073103063015500_otag081-B47","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41395-018-0233-2","article-title":"Population density and IBD risk","volume":"114","author":"Ng","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"2026073103063015500_otag081-B48","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/MIB.0000000000000313","article-title":"Korea IBD incidence","volume":"21","author":"Kim","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"2026073103063015500_otag081-B49","doi-asserted-by":"publisher","first-page":"otaf014","DOI":"10.1093\/crocol\/otaf014","article-title":"PAIR survey SDM","volume":"7","author":"Hirai","year":"2025","journal-title":"Crohns Colitis 360"},{"key":"2026073103063015500_otag081-B50","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/01.MIB.0000441348.32570.34","article-title":"CCFA partner validation","volume":"20","author":"Randell","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"2026073103063015500_otag081-B51","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.crohns.2013.09.012","article-title":"Self-reported medical history accuracy","volume":"8","author":"Kelstrup","year":"2014","journal-title":"J Crohns Colitis"}],"container-title":["Crohn\u2019s &amp; Colitis 360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/advance-article-pdf\/doi\/10.1093\/crocol\/otag081\/69028442\/otag081.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/article-pdf\/8\/3\/otag081\/69028442\/otag081.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/article-pdf\/8\/3\/otag081\/69028442\/otag081.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T07:06:40Z","timestamp":1785481600000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/article\/doi\/10.1093\/crocol\/otag081\/8735848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7,8]]}},"URL":"https:\/\/doi.org\/10.1093\/crocol\/otag081","relation":{},"ISSN":["2631-827X"],"issn-type":[{"value":"2631-827X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,7]]},"article-number":"otag081"}}